Sarepta Therapeutics (SRPT) Stock PT Cut in Half at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Kostas Biliouris lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $25.00 (from $50.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
